Status
Conditions
Treatments
About
The goal of this clinical trial is to evaluate whether auricular acupressure combined with basic care can improve symptoms in postpartum women with blocked milk ducts after cesarean delivery. The main questions it aims to answer are:
Participants will:
Full description
This randomized, single-blind, controlled clinical trial aims to evaluate the effectiveness and safety of auricular acupressure combined with basic breast care in postpartum women with blocked milk ducts following cesarean delivery.
Participants who meet the eligibility criteria will be randomly assigned to either the intervention group (auricular acupressure plus basic breast care) or the control group (sham auricular acupressure plus basic breast care). Auricular acupressure will be applied using semi-permanent auricular pellets at therapeutic ear acupoints on the ear ipsilateral to the affected breast, while the control group will receive sham intervention at non-therapeutic points. Both groups will receive standardized basic breast care, including frequent breastfeeding or milk expression, breast massage during feeding, and warm compresses before feeding.
The intervention will be administered over 3 consecutive days. Participants will be instructed and supervised by trained midwives and will perform self-care during the study period. Outcomes will be assessed at baseline and daily during the intervention period.
The primary outcome is the change in breast pain score measured by the Numeric Rating Scale (NRS). Secondary outcomes include changes in the severity of blocked milk ducts, use of rescue analgesic medication, and incidence of adverse events.
This study is designed as a pilot randomized controlled trial to preliminarily evaluate the effectiveness and feasibility of auricular acupressure combined with basic breast care in postpartum women with blocked milk ducts following cesarean delivery. Due to the lack of prior studies for accurate sample size estimation, the sample size was determined based on recommendations for pilot studies, with a minimum of 30 participants per group. Allowing for a 10% dropout rate, the total sample size is set at 66 participants (33 per group). The results of this pilot study will inform the design and sample size calculation of a future definitive randomized controlled trial.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Participants must meet all of the following criteria:
Exclusion criteria
Participants meeting any of the following criteria will be excluded:
Primary purpose
Allocation
Interventional model
Masking
66 participants in 2 patient groups
Loading...
Central trial contact
Huy Chung Ly, MD, PhD; Duyen Lam My Le, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal